Jack L. Harbert
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
- Antimicrobial Resistance in Staphylococcus 1
- Co-authors
- Richard S. Vander Heide (3 shared papers)Sharon Fox (2 shared papers)J. Quincy Brown (2 shared papers)Guang Li (1 shared paper)Steven L. Barriere (1 shared paper)James W. Janc (1 shared paper)Verena van der Heide (1 shared paper)Martha Campbell‐Thompson (1 shared paper)
- Journals
- The Lancet Respiratory Medicine (1 paper)Circulation (1 paper)American Journal of Clinical Pathology (1 paper)Journal of Thrombosis and Thrombolysis (1 paper)SSRN Electronic Journal (1 paper)
- Partner nations
- United StatesGermanyTaiwan
In The Last Decade
Jack L. Harbert
4 papers receiving 1.1k citations
Jack L. Harbert's Hit Papers
Peers
Comparison fields: 5 of 80
- Infectious Diseases 772
- Internal Medicine 111
- Neurology 375
- Critical Care and Intensive Care Medicine 40
- Dermatology 69
Countries citing papers authored by Jack L. Harbert
This map shows the geographic impact of Jack L. Harbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack L. Harbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack L. Harbert more than expected).
Fields of papers citing papers by Jack L. Harbert
This network shows the impact of papers produced by Jack L. Harbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack L. Harbert. The network helps show where Jack L. Harbert may publish in the future.
Co-authors
The 25 scholars most cited alongside Jack L. Harbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans Hit paper breakdown → | 2020 | 983 |
| 2 | 2020 | 117 | |
| 3 | 2013 | 6 | |
| 4 | 2020 | 1 | |
| 5 | 2022 | 0 |
About Jack L. Harbert
Jack L. Harbert is a scholar working on Infectious Diseases, Molecular Biology, Cardiology and Cardiovascular Medicine, Internal Medicine and Oncology, having authored 5 papers that have together received 1.1k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Venous Thromboembolism Diagnosis and Management (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Cardiovascular Effects of Exercise (1 paper), Eosinophilic Disorders and Syndromes (1 paper), Antimicrobial Resistance in Staphylococcus (1 paper) and Sepsis Diagnosis and Treatment (1 paper). The work is most often cited by research in Infectious Diseases (772 citations), Internal Medicine (111 citations), Neurology (375 citations), Critical Care and Intensive Care Medicine (40 citations) and Dermatology (69 citations). Jack L. Harbert has collaborated with scholars based in United States, Germany and Taiwan. Frequent co-authors include Richard S. Vander Heide, Sharon Fox, J. Quincy Brown, Guang Li, Guang Li, Steven L. Barriere, James W. Janc, Verena van der Heide, Martha Campbell‐Thompson and Alberto Pugliese. Their work appears in journals such as The Lancet Respiratory Medicine, Circulation, American Journal of Clinical Pathology, Journal of Thrombosis and Thrombolysis and SSRN Electronic Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.